| Application no. and date | 17718256.5 (espacenet) (Federated) (European Patent Register), 20170404 | | Patent/reg. no. and date | DK/EP 3439662, 20240724 | | Publication date | 20190213 | | Priority no. and date | US 201662318041 P, 20160404, US 201662323452 P, 20160415, US 201662329561 P, 20160429 | | EP pub. no. and date |
EP 3439662 20190213 | | Effective date | | | Applicant/owner | Loxo Oncology Inc., 281 Tresser Boulevard 9th Floor
Stamford, Connecticut 06901, US | | Applicant ref. no. | BB262703EPDK | | Inventor | REYNOLDS, Mark, 281 Tresser Blvd. 9th Floor
Stamford
Connecticut 06901, US,
SMITH, Steven A., 281 Tresser Blvd. 9th Floor
Stamford
Connecticut 06901, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) | | Title | VÆSKEFORMIGE FORMULERINGER AF (S)-N-(5-((R)-2-(2,5-DIFLUORPHENYL)-PYRROLIDIN-1-YL)-PYRAZOL[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDIN-1-CARBOXAMID | | Int. application no. | US2017025939 | | Int. publication no. | WO2017176751 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
